Key statistics
On Monday, Xeris Biopharma Holdings Inc (2B30:BER) closed at 2.51, -17.50% below its 52-week high of 3.04, set on Feb 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.63 |
---|---|
High | 2.66 |
Low | 2.50 |
Bid | 2.43 |
Offer | 2.63 |
Previous close | 2.63 |
Average volume | 11.57k |
---|---|
Shares outstanding | 149.00m |
Free float | 143.17m |
P/E (TTM) | -- |
Market cap | 436.57m USD |
EPS (TTM) | -0.4215 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 19:08 BST.
More ▼
Press releases
- Xeris to Participate in Upcoming Investor Conferences
- Xeris Biopharma Reports Second Quarter 2024 Financial Results
- Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024
- Xeris Biopharma Announces CEO Succession Plan
- Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
More ▼